Login

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Q2 FY2021
As of Jun 30, 2021
Q1 FY2021
As of Mar 31, 2021
ASSETS
Current assets
Cash
Prepaid expenses and other current assets
Total Current Assets
Investments held in Trust Account
Total Assets
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current liabilities
Accrued expenses
Income taxes payable
Sponsor convertible note
Total Current Liabilities
Warrant liability – private placement
Warrant liability – public
Warrant liabilities – Private Placement
Warrant liabilities – Public Warrants
Deferred underwriting fee payable
Total Liabilities
Class A common stock subject to possible redemption, $0.0001 par value; 34,500,000 shares at approximately $10.04 and $10.00 per share redemption value as of September 30, 2022 and December 31, 2021, respectively
Stockholders’ Deficit
Class A common stock, $0.0001 par value; 100,000,000 shares authorized; no shares issued or outstanding (excluding 34,500,000 shares subject to possible redemption) as of September 30, 2022 and December 31, 2021
Class B common stock, $0.0001 par value; 10,000,000 shares authorized; 8,625,000 shares issued and outstanding as of September 30, 2022 and December 31, 2021
Accumulated deficit
Total Stockholders’ Deficit
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support